BCL9 and schizophrenia: We found that CHD1L is a candidate for autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) (25, 26), whereas PRKAB2 and BCL9 have been associated to schizophrenia (27–30).